利用人工智能开发内镜超声卷积神经网络模型以提高自身免疫性胰腺炎的诊断
本研究利用583例患者(146例自身免疫性胰腺炎、292例胰腺导管腺癌、72例慢性胰腺炎、73例正常胰腺)的1174461张内镜超声图像开发卷积神经网络模型。视频分析中模型每秒处理955帧,区分自身免疫性胰腺炎与正常胰腺的敏感度99%、特异度98%,与慢性胰腺炎为94%和71%,与胰腺导管腺癌为90%和93%,与所有研究条件为90%和85%。
要点
- 内镜超声卷积神经网络模型可准确区分自身免疫性胰腺炎与胰腺导管腺癌及良性胰腺疾病。
- 模型每秒处理955帧内镜超声视频,具备实时分析能力。
- 模型区分自身免疫性胰腺炎与胰腺导管腺癌的敏感度90%、特异度93%。
核心结论
- 开发的内镜超声卷积神经网络模型能准确区分自身免疫性胰腺炎与胰腺导管腺癌及良性胰腺疾病,从而提供更早、更准确诊断的能力。
- 使用该模型有可能带来更及时、更合适的患者照护并改善结局。
研究设计与样本
- 利用自身免疫性胰腺炎、胰腺导管腺癌、慢性胰腺炎和正常胰腺的内镜超声检查所获静态图像和视频数据库开发卷积神经网络。
- 数据库来自583例患者,包括146例自身免疫性胰腺炎、292例胰腺导管腺癌、72例慢性胰腺炎和73例正常胰腺,共提取1174461张独特内镜超声图像。
- 采用遮挡热图分析识别卷积神经网络在区分自身免疫性胰腺炎与胰腺导管腺癌时所重视的超声特征。
主要发现
- 视频数据中,卷积神经网络每秒处理955帧内镜超声图像。
- 区分自身免疫性胰腺炎与正常胰腺:敏感度99%,特异度98%。
- 区分自身免疫性胰腺炎与慢性胰腺炎:敏感度94%,特异度71%。
- 区分自身免疫性胰腺炎与胰腺导管腺癌:敏感度90%,特异度93%。
- 区分自身免疫性胰腺炎与所有研究条件(即胰腺导管腺癌、慢性胰腺炎和正常胰腺):敏感度90%,特异度85%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The diagnosis of autoimmune pancreatitis (AIP) is challenging. Sonographic and cross-sectional imaging findings of AIP closely mimic pancreatic ductal adenocarcinoma (PDAC) and techniques for tissue sampling of AIP are suboptimal. These limitations often result in delayed or failed diagnosis, which negatively impact patient management and outcomes. This study aimed to create an endoscopic ultrasound (EUS)-based convolutional neural network (CNN) model trained to differentiate AIP from PDAC, chronic pancreatitis (CP) and normal pancreas (NP), with sufficient performance to analyse EUS video in real time. DESIGN: A database of still image and video data obtained from EUS examinations of cases of AIP, PDAC, CP and NP was used to develop a CNN. Occlusion heatmap analysis was used to identify sonographic features the CNN valued when differentiating AIP from PDAC. RESULTS: From 583 patients (146 AIP, 292 PDAC, 72 CP and 73 NP), a total of 1 174 461 unique EUS images were extracted. For video data, the CNN processed 955 EUS frames per second and was: 99% sensitive, 98% specific for distinguishing AIP from NP; 94% sensitive, 71% specific for distinguishing AIP from CP; 90% sensitive, 93% specific for distinguishing AIP from PDAC; and 90% sensitive, 85% specific for distinguishing AIP from all studied conditions (ie, PDAC, CP and NP). CONCLUSION: The developed EUS-CNN model accurately differentiated AIP from PDAC and benign pancreatic conditions, thereby offering the capability of earlier and more accurate diagnosis. Use of this model offers the potential for more timely and appropriate patient care and improved outcome.
引用
- Marya NB, Powers PD, Chari ST, et al. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis. Gut. 2020. PMID: 33028668. doi:10.1136/gutjnl-2020-322821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。